← Back to all trials
Recruiting
NCT07538570
Evaluation of Pain Treatment After Total Knee Arthroplasty
Conditions: Pain
Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 60
Sponsor: Vertex Pharmaceuticals Incorporated
Location: Legent Orthopedic and Spine Hospital Bellaire Texas
Summary
The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).
Eligibility Criteria
Key Inclusion Criteria:
* Body mass index (BMI) of greater than or equal to (≥) 18.0 to less than or equal to (≤) 40.0 kilogram per meter square (kg/m\^2)
* Scheduled to undergo an elective primary unilateral TKA surgery
Key Exclusion Criteria:
\- History of previous TKA surgery on incident side
Other protocol defined Inclusion/Exclusion criteria will apply.
Source: ClinicalTrials.gov (NCT07538570). StuddyBuddy aggregates publicly available trial information.
